Medication info
Ducadipin 60/2.5 mg Tablet

Ducadipin 60/2.5 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Yellow, rounded rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300119 · Approved 2023.01.06 · Insurance code 640904440

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with the 30 mg fimasartan dose of this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medicine is used in patients with essential hypertension whose blood pressure is not adequately controlled with Pimasartan Potassium monotherapy.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with the 30 mg fimasartan dose of this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients who have allergies to this medication's active ingredients or similar compounds, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with moderate to severe liver impairment, patients with bile duct obstruction, certain kidney disease patients, patients with lactose intolerance, patients with severe aortic stenosis, patients in shock, etc., should not take this medication. Patients with reduced blood volume or reduced renal function, patients with renal artery hypertension, patients with aortic and mitral valve stenosis, patients with severe hypotension, elderly patients, and those with allergies to certain pigments should take this medication with caution, ensuring close monitoring of their condition. This medication can cause a variety of side effects, including headache, dizziness, facial swelling, urination disturbances, insomnia, and flushing; if these symptoms persist or worsen, consultation with healthcare professionals is advised. During the initial intake or when increasing the dosage, blood pressure may drop too low, so attention should be paid to symptoms of hypotension, and if blood pressure becomes too low, the patient should be laid down and, if necessary, receive fluid therapy. Especially in patients with heart failure or weakened kidney function, there is a risk of elevated potassium levels in the blood, necessitating regular blood tests. This medication can interact with other antihypertensives, diuretics, potassium supplements, certain antibiotics, and analgesics; therefore, patients should inform healthcare professionals of any concurrent medications. Women who are pregnant or breastfeeding are advised against taking this medication, and if necessary, should consult their physician to use safe alternative medications. Children under 18 years of age should not use this medication, as its safety and efficacy in this population have not been established. In cases of overdose, severe hypotension, cardiac arrhythmias, shock, etc., may occur, so immediate emergency treatment is required; caution should also be exercised as blood pressure may recover slowly after discontinuation. This medication should be kept out of reach of children and stored in its original packaging to maintain its quality.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • dysuria
  • insomnia
  • flushing
  • syncope
  • sedation
Show 138 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzymes
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • fracture
  • chest pain
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • taste abnormalities
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbance
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • hypotension
  • palpitations
  • bradycardia
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a light-resistant container. Additionally, it is important to store it in a cool room temperature, between 1°C and 30°C, to maintain its effectiveness.

Appearance and packaging

Appearance

Yellow, rounded rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.